SLRX
Salarius Pharmaceuticals (SLRX)
$86
About Salarius Pharmaceuticals (SLRX)
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. The company was founded in February 2014 and is headquartered in Houston, TX.
Details
Daily high
$0.86
Daily low
$0.83
Price at open
$0.85
52 Week High
$7.20
52 Week Low
$0.83
Market cap
1.5M
Dividend yield
0.00%
Volume
32,734
Avg. volume
181,422
P/E ratio
-.11
Salarius Pharmaceuticals News
Details
Daily high
$0.86
Daily low
$0.83
Price at open
$0.85
52 Week High
$7.20
52 Week Low
$0.83
Market cap
1.5M
Dividend yield
0.00%
Volume
32,734
Avg. volume
181,422
P/E ratio
-.11